The uPath HER2 Dual ISH IA algorithm (Roche Ventana, Tucson, AZ, USA) was designed to assist pathologists in HER2 gene quantification using bright-field ISH in breast cancer [20]. Here, ERBB2 is linked to breast carcinoma.